Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

Investigation of Metabolite Differences Between Taiwanese Metabolic Syndrome and Healthy Group Through Metabolomics

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06363864

Enrollment

1200

Registered

2024-04-12

Start date

2024-04-14

Completion date

2029-10-31

Last updated

2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Brief summary

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Capable adults weigh ≥ 50 kg

Exclusion criteria

* Not Taiwanese * Having received oral antibiotics, immunosuppressants, and chemotherapy drugs in the past month * Incapacity * Limited disposing capacity * Mental disorders or intellectual disabilities

Design outcomes

Primary

Measure	Time frame	Description
Concentration changes of small molecules in blood.	Up to six years	Concentrations of small molecules in healthy individuals and metabolic syndrom patients will be analyzed to identify specific biomarkers for metabolic syndrome.

Outcome results